Biomarker prognostication across Universal Definition of Heart Failure stages.

Biomarker prognostication across Universal Definition of Heart Failure stages.
复制标题

DOI:
10.1002/ehf2.14071
复制
发表时间:
2022-12
期刊:
影响因子:
3.8
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

The Universal Definition of Heart Failure (UDHF) provides a framework for staging risk for HF events. It is not clear whether prognostic biomarkers have different meaning across UDHF stages. We sought to evaluate performance of biomarkers to predict HF events among high‐risk patients undergoing coronary and/or peripheral angiography categorized into UDHF stages. One thousand two hundred thirty‐five individuals underwent coronary and/or peripheral angiography were enrolled. Study participants were categorized into UDHF Stage A (at risk), Stage B (pre‐HF), and Stage C or D (HF, including end stage) and grouped into Stage A/B and C/D. Biomarkers and clinical variables were used to develop prognostic models. Other measures examined included total HF hospitalizations. Over a median of 3.67 years of follow‐up, 155 cardiovascular (CV) deaths occurred, and 299 patients were hospitalized with acute HF. In patients with Stage A/B, galectin‐3 (HR = 1.52, P = 0.03), endothelin‐1 (HR = 2.16, P = 0.001), and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP; HR = 1.43, P < 0.001) were associated with incident CV death/HF hospitalization. In Stage C/D, NT‐proBNP (HR = 1.26, P = 0.006), soluble urokinase‐type plasminogen activator receptor (suPAR; HR = 1.57, P = 0.007) and high‐sensitivity C‐reactive protein (hs‐CRP; HR = 1.15, P = 0.01) were associated with these outcomes. Higher biomarker concentrations were associated with greater total burden of HF events in Stages A/B and C/D. Among higher risk individuals undergoing angiographic procedures, different biomarkers improve risk stratification in different UDHF stages of HF. More precise prognostication may offer a window of opportunity to initiate targeted preventive measures.
DOI: 10.1002/ejhf.203
发表时间: 2015-02-01
影响因子: 18.2
作者:
Edelmann, Frank;Holzendorf, Volker;Pieske, Burkert M.
通讯作者: Pieske, Burkert M.
DOI: 10.1056/nejm199306173282402
发表时间: 1993-06-17
影响因子: 158.5
作者:
GIAID, A;YANAGISAWA, M;STEWART, DJ
通讯作者: STEWART, DJ
DOI: 10.1016/j.jchf.2018.10.014
发表时间: 2019-02-01
期刊: JACC-HEART FAILURE
影响因子: 13
作者:
Daubert, Melissa A.;Adams, Kirkwood;Felker, G. Michael
通讯作者: Felker, G. Michael
DOI: 10.1001/jamacardio.2016.0962
发表时间: 2016-07-01
期刊: JAMA CARDIOLOGY
影响因子: 24
作者:
Jankowich, Matthew D.;Wu, Wen-Chih;Choudhary, Gaurav
通讯作者: Choudhary, Gaurav
DOI: 10.1016/j.jacc.2018.11.049
发表时间: 2019-03-05
影响因子: 24
作者:
Butler, Javed;Yang, Mei;Givertz, Michael M.
通讯作者: Givertz, Michael M.